Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. - Wikidata - thesis-toulmin - TriplyDB

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

http://www.wikidata.org/entity/Q33909897

about

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial Role of Inflammation in Muscle Homeostasis and Myogenesis Mechanisms of metabolic dysfunction in cancer-associated cachexia Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases Cancer cachexia: a therapeutic approach.Vitamin D and VDR in cancer cachexia and muscle regeneration.Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation.Cytokines and cancer anorexia cachexia syndrome.Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.Optimal management of cancer anorexia-cachexia syndrome.The feasibility and efficacy of eccentric exercise with older cancer survivors: a preliminary study Nutrition modulation of cachexia/proteolysis.Cancer cachexia, mechanism and treatment Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.XIAP reduces muscle proteolysis induced by CKD.Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment Adult patients are more catabolic than children during acute phase after burn injury: a retrospective analysis on muscle protein kinetics.An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy Leptin in anorexia and cachexia syndrome.Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).Rikkunshito Ameliorates Cancer Cachexia Partly through Elevation of Glucarate in Plasma The cancer cachexia syndrome: a review of metabolic and clinical manifestations.TNF-alpha is involved in activating DNA fragmentation in skeletal muscle Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.Emerging drugs for cancer cachexia.Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.Anti-cytokine strategies for the treatment of cancer-related anorexia and cachexia.Respiratory diseases and muscle dysfunction.Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants.Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.Thermoregulation as a disease tolerance defense strategy.Development of features of glomerulopathy in tumor-bearing rats: a potential model for paraneoplastic glomerulopathy.Knockdown of metallothionein 1 and 2 does not affect atrophy or oxidant activity in a novel in vitro model.Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-α.Are tumoral factors responsible for host tissue wasting in cancer cachexia?

P2860

Q24555065-F1828F66-8D16-4168-9718-D35601F65189 Q24685678-E5AA7B2C-9CB2-4407-B602-9F1C6D2EFE0D Q26778322-F77FE683-C3E1-451E-97F2-511AD35D597C Q28079213-2F9AB767-B03C-401D-AC8F-D6895C0D6362 Q28344272-CE78EF98-99C5-4950-86E0-7B1C445E4A7C Q28389456-2CF87CD7-8761-429F-9AA4-CDE1E159F5BB Q31791590-64FCEAD3-C7F9-4A3D-A7D0-3ADBB3706AFE Q33591678-FF18CABC-257F-41C5-8742-C0BF185CD967 Q33988273-0C259D46-B392-46FE-BED5-307752387915 Q34011011-A8706FFC-D6F2-4965-8FB1-4B0F0719E59D Q34400107-F3B29C2C-049C-44ED-B283-7BCA908B9FA9 Q34417908-E4ACE8FE-9197-4C54-970E-65F500F52ADC Q34479799-ACF16081-52E3-40C7-B366-47DAB5B172C5 Q34565917-ABD44B43-2773-4F30-A859-6CFA242F7BD1 Q34669440-764CEC2E-34F8-4D13-BC1F-04061D861F51 Q34716943-1A77EC7B-CED9-484F-9C5B-245C05793A7B Q35103083-B81831B0-D49B-4AD1-96A8-F83B06E7A54F Q35120883-2578DADF-BAB5-4ACF-8FEB-EC6EDDF97748 Q35153178-48056F19-0B63-4FF7-BE1C-293ADCC521FC Q35555818-F39248C4-83D4-4E90-BF84-F100E8CAA7FB Q35760701-90B9F39C-C341-490F-803E-4F6C5CFCB17F Q35783526-5AF4B889-54FC-4CF4-9A93-F526653C5AE2 Q35787728-7085CEC8-A5C7-409D-ADF8-A625E7EA93F6 Q35829778-AA9C7C66-3295-48F7-B00C-E43F61FE0694 Q36081293-F09194FB-A1F5-4220-9BE6-95B0A30D889C Q36103348-34CBC501-1324-4FD5-B3CB-9A89FECC6F64 Q36278394-2038056D-EE76-4513-AD86-4732AF63CB74 Q36623740-6C810621-78ED-4F66-871C-B92FB8C91145 Q36642208-C1E5D958-0A73-42B7-AE35-5B068660EA3B Q36989913-DCB3DAF3-A63F-41AD-9866-75E21B06A55C Q37042189-83B047E8-08AC-494D-B375-CB9937D5C35C Q37769250-D525B257-C572-4A2D-BAE4-028B05BCFE0A Q37979250-F7875215-5562-4720-8BD5-75C11C014427 Q38359041-6B1E6FB2-3E7D-4146-84C7-DF6824118EB1 Q38802465-9EE1CB0A-FD32-4675-B71B-F701E37C5903 Q38999142-AC560903-C1F9-482B-8E68-7C0509BE3982 Q39453326-8AC34F4D-C6FF-4DD5-BDBD-EBD2E3363F9C Q39662824-9170E580-B78A-43CB-8785-BECDFB1404F3 Q39681574-6A9ED316-EA78-4E41-9432-E3D198571052 Q39885110-D352A806-C2D8-4364-9190-0B26FEFCDBA9

P2860

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

http://www.wikidata.org/entity/Q33909897

description

1993 nî lūn-bûn

@nan

1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@ast

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@en

type

label

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@ast

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@en

prefLabel

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@ast

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@en

P1433

Q33909897-4791C231-2546-450C-A7B9-1B3F097408CC

P1476

Q33909897-7F7A734E-19FE-4C02-8F10-24DBAAFD0050

P2093

Q33909897-26E1645F-5D73-4E54-BDC5-B9A69CB112FF

Q33909897-3A0894C7-613E-4D3B-8DCF-133D5321FE80

Q33909897-50EA1E76-1157-417B-A1E3-D1B16B5F209E

Q33909897-7101E731-B828-4B7A-9F2A-D739866DB932

Q33909897-786C5C3E-3067-4069-BF4A-702739E405D8

Q33909897-9443CF39-E551-4185-B759-2554D04E75D3

Q33909897-FF46BC04-5000-4964-8167-906736E6E092

P2860

Q33909897-14EE1BA0-676B-4C05-B82F-8202D5146282

Q33909897-1E28E188-4103-41F2-9D67-1A65D0E6CBBD

Q33909897-1EA96C94-1898-4EB8-A1F3-63CEEDF64D5A

Q33909897-2FE2C224-CEBA-4938-8C14-1FA83D30A9D6

Q33909897-334F5695-34FF-4ADA-90D9-8A86B0736285

Q33909897-335EC742-51C8-406C-BB15-F38CEA9F0782

Q33909897-46AEA088-9940-4CE1-8BB7-70ACA2DCC71C

Q33909897-46ED6C58-FE7B-434E-9A3F-86F05BA04CE2

Q33909897-4C386723-5AC9-4377-82D5-E0B6CA80285E

Q33909897-5D45EF5D-95C5-4AA6-B49C-373E872BEA07

P304

Q33909897-5CB852FF-0E92-467E-8D2B-F503B5A3A29D

P31

Q33909897-E0864812-23FA-44B4-A35B-16D22EECAAFD

P356

Q33909897-32328500-ACAE-461C-B581-0D28F1B3CCC0

P407

Q33909897-AB9684F9-15E8-4A5F-8FE7-2A8535396732

P433

Q33909897-567D7271-95AB-496B-86A8-B47E6BE3AAF9

P478

Q33909897-F56B0C06-6590-4D1F-B0DE-05AC96D2CA59

P577

Q33909897-2D04DD3C-6137-4D01-A7D8-7A7FA2A83306

P5875

Q33909897-D32F2699-747E-4D9C-90DD-5B8B52BE92F5

P698

Q33909897-4E19F0B5-290D-49F5-B8D9-02DF9F6E49CB

P932

Q33909897-5A36E1B5-30EC-457F-BAF8-9E18FBFE7DE6

P356

P1433

Journal of Clinical Investigation

P1476

Tumor necrosis factor-alpha me ...... n a rat cancer cachexia model.

@en

P2093

F J Lopez-Soriano

http://www.w3.org/2001/XMLSchema#string

F M Baccino

http://www.w3.org/2001/XMLSchema#string

G J Bagby

http://www.w3.org/2001/XMLSchema#string

J M Argilés

http://www.w3.org/2001/XMLSchema#string

L Tessitore

http://www.w3.org/2001/XMLSchema#string

N Carbó

http://www.w3.org/2001/XMLSchema#string

P Costelli

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1

The role of cytokines in muscle wasting: its relation with cancer cachexia.

Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.

Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue

Humoral mediation for cachexia in tumour-bearing rats.

Tumour necrosis factor in man: clinical and biological observations.

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.

Newly identified factors that alter host metabolism in cancer cachexia.

P304

2783-2789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116897

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1993-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14945324

http://www.w3.org/2001/XMLSchema#string

P698

8254032

http://www.w3.org/2001/XMLSchema#string

P932

288478

http://www.w3.org/2001/XMLSchema#string